Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Glaxosmithkline plc symbols : Adap save search
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
Published: 2023-04-11 (Crawled : 15:20) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -1.27%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -1.77%
H: 11.71%
C: 9.01%
transfer back
Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -3.13%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.61%
H: 0.08%
C: -0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.29%
H: 1.55%
C: 1.2%
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: -0.57%
H: 5.9%
C: 5.44%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.23%
H: 0.79%
C: 0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -0.99%
H: 6.5%
C: 3.0%
research report therapy cancer market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 0.66%
H: 1.22%
C: -5.83%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.08%
H: 0.45%
C: -0.13%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 1.85%
H: 6.67%
C: 3.03%
treatment therapy cancer market
Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.4%
H: 7.54%
C: 7.54%
CYTR | $0.092
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.12%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.1%
H: 0.1%
C: -1.62%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -1.86%
H: 4.92%
C: -1.52%
program therapeutics growth
Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.25%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.58%
H: 4.05%
C: 2.02%
cancer diagnostics kidney diagnostic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.